Beyond Air appoints David Webster as Chief Commercial Officer effective July 8, 2024

Beyond Air, Inc.

David Webster appointed CCO, effective July 8, 2024, with over 20 years life sciences experience.
Previously CEO of Body Vision Medical; led commercialization of Lung Vision system.
Received inducement stock option for 125,000 shares, vesting over four years starting July 8, 2024.
Company expects Webster to drive LungFit PH market share gains and strengthen commercial team.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.